Aims This study aims to examine the effectiveness of using sodium glucose transporter-2
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

The worldwide COVID‑19 pandemic was brought on by a new coronavirus (SARS Cov‑2). A
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …

BACKGROUND: The coronavirus pandemic has had an extremely negative impact on the
patients with diabetes mellitus (DM both in terms of a more severe course of COVID-19 and …

Early since the onset of the COVID-19 pandemic, the medical and scientific community were
aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation …

Актуальность. Пандемия коронавирусной инфекции внесла крайне негативный вклад в
аспекты ведения пациентов с сахарным диабетом (СД), ставших «мишенью» вируса …

Пандемия COVID-19 оказала серьезное влияние на мировое здравоохранение и
показала, что нынешнее состояние большинства систем здравоохранения в мире …

During 2020–2023, Mexico had a large COVID-19 emergency with> 331,000 adult deaths
and one of the highest excess mortalities worldwide. Age at COVID-19 death has been …

Diabetes mellitus (DM) is among the major global public health issues. According to recent
projections, a continued rise in DM prevalence is expected in the following decades. The …

Aims Inflammation can trigger hyperglycemia in people with type 1 diabetes (T1D). Vaccines
purposefully intend to cause an acute immunogenic response, and booster vaccines may …